162 related articles for article (PubMed ID: 29615489)
1. Long-term proton pump inhibitors use and risk of gastric cancer: a meta-analysis of 926 386 participants.
Wan QY; Wu XT; Li N; Du L; Zhou Y
Gut; 2019 Apr; 68(4):762-764. PubMed ID: 29615489
[No Abstract] [Full Text] [Related]
2. Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for
Niikura R; Hayakawa Y; Hirata Y; Yamada A; Fujishiro M; Koike K
Gut; 2018 Oct; 67(10):1908-1910. PubMed ID: 29273641
[No Abstract] [Full Text] [Related]
3. Long-term proton pump inhibitor use after
Kobayashi J; Uchida H; Ito J
Gut; 2019 Jun; 68(6):1131. PubMed ID: 29802173
[No Abstract] [Full Text] [Related]
4.
Suzuki H; Matsuzaki J
Gut; 2018 Nov; 67(11):2071-2072. PubMed ID: 29247066
[No Abstract] [Full Text] [Related]
5. Proton pump inhibitors and gastric cancer: association is not causation.
Moayyedi P; Veldhuyzen van Zanten SJO; Hookey L; Armstrong D; Jones N; Leontiadis GI
Gut; 2019 Aug; 68(8):1529-1530. PubMed ID: 30006494
[No Abstract] [Full Text] [Related]
6. Proton pump inhibitors and risk of gastric cancer in a case-control study.
Lai SW; Lai HC; Lin CL; Liao KF
Gut; 2019 Apr; 68(4):765-767. PubMed ID: 29661803
[No Abstract] [Full Text] [Related]
7. Risk factors for gastric cancer: is it time to discard PPIs?
Laterza L; Scaldaferri F; Gasbarrini A
Gut; 2019 Jan; 68(1):176-177. PubMed ID: 29331945
[No Abstract] [Full Text] [Related]
8. Proton pump inhibitors and risk for gastric cancer: Is it real?
Akriviadis E; Liava C
Turk J Gastroenterol; 2019 Mar; 30(3):309-310. PubMed ID: 30923034
[No Abstract] [Full Text] [Related]
9. OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer.
Arai J; Niikura R; Hayakawa Y; Aoki T; Yamada A; Kawai T; Fujishiro M
Gut; 2022 May; 71(5):1043-1044. PubMed ID: 34344784
[No Abstract] [Full Text] [Related]
10. Rationale for a Helicobacter pylori Test and Treatment Strategy in Gastroesophageal Reflux Disease.
Vakil N
Gastroenterol Clin North Am; 2015 Sep; 44(3):661-6. PubMed ID: 26314675
[TBL] [Abstract][Full Text] [Related]
11. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
Lee YC; Chiang TH; Chou CK; Tu YK; Liao WC; Wu MS; Graham DY
Gastroenterology; 2016 May; 150(5):1113-1124.e5. PubMed ID: 26836587
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and gastric neoplasia.
Kuipers EJ
Gut; 2006 Sep; 55(9):1217-21. PubMed ID: 16905689
[TBL] [Abstract][Full Text] [Related]
13. Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.
Miyamoto S; Kato M; Matsuda K; Abiko S; Tsuda M; Mizushima T; Yamamoto K; Ono S; Kudo T; Shimizu Y; Hatanaka KC; Tsunematsu I; Sakamoto N
Intern Med; 2017; 56(14):1825-1829. PubMed ID: 28717077
[TBL] [Abstract][Full Text] [Related]
14. Response to letter to the editor by Moayyedi
Cheung KS; Leung WK
Gut; 2019 Sep; 68(9):1721-1722. PubMed ID: 30121628
[No Abstract] [Full Text] [Related]
15. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
[TBL] [Abstract][Full Text] [Related]
16. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.
Ko Y; Tang J; Sanagapalli S; Kim BS; Leong RW
Expert Opin Drug Saf; 2016 Jan; 15(1):53-63. PubMed ID: 26560097
[TBL] [Abstract][Full Text] [Related]
17. Editorial: proton pump inhibitors, Helicobacter pylori and gastric cancer--the need for long-term follow-up.
Kuipers EJ
Aliment Pharmacol Ther; 2016 Mar; 43(5):647-8. PubMed ID: 26843338
[No Abstract] [Full Text] [Related]
18. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors and the risk of gallbladder cancer: a hospital-based case-control study.
Xiong J; Wang Y; Chen G; Jin L
Gut; 2020 Dec; 69(12):2265-2267. PubMed ID: 32273291
[No Abstract] [Full Text] [Related]
20. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
